DTNB Polyclonal Antibody, RBITC Conjugated
Product Specifications
Background
Dystrobrevin beta is a component of the dystrophin-associated protein complex and interacts with dystrophin short form DP71, syntrophins SNTG1 and SNTG2. It localizes to the sarcolemma and its disruption is associated with various forms of muscular dystrophy. 4 isoforms produced by alternative splicing have been identified.
Synonyms
Dystrobrevin beta; DTN-B; Beta-dystrobrevin; DTNB
Gene ID
1838
Swiss Prot
O60941
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Rat
Immunogen
261-370/627
Target
DTNB
Clonality
Polyclonal
Isotype
IgG
Conjugation
RBITC
Source
KLH conjugated synthetic peptide derived from human DTNB
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Specificity
This antibody may cross-react with DTNA based upon a 75% sequence similarity across the immunogen sequence range.
Gene ID URL
1838
Predicted Cross Reactivity
Human, Mouse, Dog, Cow, Horse, Chicken, Rabbit
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
P1001-27E5 100 µL
P53, phosphorylated (Ser6) (Antigen NY CO 13, Antigen NY-CO-13, Cellular Tumor Antigen p53, Cys 51 Stop, HGNC:11998, LFS1, p53 Cellular Tumor Antigen, p53 Tumor Suppressor, Phosphoprotein p53, Transformation Related Protein 53, TRP53, Tumor Protein p53, TP53, Tumor Suppressor p53) discontinued
Ask
View Details 
